SCHEMBL5736835

SCHEMBL5736835

COC(=O)C(C)(C)Oc1cccc(-c2cccc(OCCc3nc(-c4ccccc4)oc3C)c2)c1

nearest known ligand 0.67

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PPARG P37231 20/20 0.67
PPARA Q07869 20/20 0.67
PPARD Q03181 6/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6309436 0.91 PPARG (0.81) PPARGPPARAPPARD
SCHEMBL5098183 0.89 PPARG (0.67) PPARGPPARAPPARD
SCHEMBL5105473 0.88 PPARA (0.82) PPARGPPARAPPARD
SCHEMBL6700443 0.87 PPARA (0.68) PPARGPPARAPPARD
SCHEMBL6697566 0.86 PPARA (0.83) PPARGPPARAPPARD
SCHEMBL6703623 0.86 PPARA (0.63) PPARGPPARAPPARD
SCHEMBL6703403 0.85 PPARA (0.75) PPARGPPARAPPARD
SCHEMBL4391433 0.85 PPARG (0.60) PPARGPPARAPPARD
SCHEMBL5737637 0.84 PPARA (0.69) PPARGPPARAPPARD
SCHEMBL6384072 0.83 PPARA (0.53) PPARGPPARAPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1615899-A1 ALPHA-SUBSTITUTED CARBOXYLIC ACIDS AS PPAR MODULATORS PFIZER INC. (US) 2006-01-18 EP disclosed
US-20050234066-A1 Alpha substituted carboxylic acids AGOURON PHARMACEUTICALS, INC. 2005-10-20 US disclosed
US-20050187266-A1 Alpha substituted carboxylic acids PFIZER INC 2005-08-25 US disclosed
WO-2004092145-A1 ALPHA SUBSTITUTED CARBOXYLIC ACID AS PPAR MODULATORS PFIZER INC. (US) 2004-10-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050234066-A1 Alpha substituted carboxylic acids PPARG, PPARA, PPARD PPARG 1/4885PPARA 2/4885PPARD 3/4885
US-20050187266-A1 Alpha substituted carboxylic acids PPARG, PPARA, PPARD PPARG 1/4885PPARA 2/4885PPARD 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.